Rumalon

for drug therapy of osteoarthritis; tissue extract of cartilage & bone containing no protein, only small molecules such as amino acids, nucleotides, small polypeptides, oligosaccharides and minerals; RN given refers to cpd with unknown MF

Also Known As:

Networked: 39 relevant articles (0 outcomes, 5 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Lequesne, M: 1 article (04/2001)
2.	Altman, R D: 1 article (09/2000)
3.	Gatterová, J: 1 article (09/2000)
4.	Gollerova, V: 1 article (09/2000)
5.	Misiureva, S V: 1 article (09/2000)
6.	Pavelká, K: 1 article (09/2000)
7.	Sedlácková, M: 1 article (09/2000)
8.	Urbanová, Z: 1 article (09/2000)
9.	Zupanets, I A: 1 article (09/2000)
10.	Becker, E W: 1 article (02/2000)

Related Diseases

1.	Osteoarthritis 07/01/1983 - "[Histological study of the effect of Rumalon on experimentally induced arthrosis of the knee in the rabbit]." 03/01/1970 - "A double-blind controlled trial of Rumalon in the treatment of painful osteoarthrosis of the hip." 05/01/1978 - "Treatment of osteoarthritis with Rumalon R." 04/21/1977 - "[Long-term treatment of arthrosis using Arumalon]." 01/01/1972 - "[Rumalon in the therapeutic plan for osteoarthritis]."
2.	Hip Osteoarthritis (Coxarthrosis) 10/01/1975 - "[Our experiences with the treatment of coxarthrosis by Rumalon (author's transl)]." 11/01/1974 - "[Long-term treatment of coxarthrosis using Rumalon. " 01/01/1989 - "A single-blind, placebo-controlled study of glycosaminoglycan-peptide complex ('Rumalon') in patients with osteoarthritis of the hip or knee." 09/01/2000 - "To determine the structure (disease) modifying effect of a glycosaminoglycan polypeptide association complex (GP-C; Rumalon) in patients with knee and hip osteoarthritis (OA). " 04/01/2001 - "A 5-year randomized controlled double-bling study of glycosaminoglycan polysulfuric acid complex (Rumalon) as a structure-modifying therapy in osteoarthritis of the hip and knee. "
3.	Joint Diseases (Joint Disease) 02/29/1972 - "[Seven-year therapeutic experiences with Rumalon in degenerative joint diseases of various localisations]." 01/01/1969 - "[Use of rumalon in joint diseases]." 02/01/1965 - "[RECENT EXPERIENCE IN THE TREATMENT OF JOINT DISEASES WITH "ARUMALON"]." 01/01/1993 - "The effect of glycosaminoglycan-peptide complex (GPC) (Rumalon, made by Robapharm, Switzerland) on cells of the inflammatory periarticular infiltrate and on the articular chondrocytes was studied in experimentally induced papain arthropathy by means of image cytometry and biochemistry. "
4.	Rheumatoid Arthritis 01/01/1984 - "[Erroneous prescription of rumalon to rheumatoid arthritis patients]." 01/01/1984 - "The author describes 2 cases of erroneous prescription of rumalon to patients with rheumatoid arthritis (RA), as a result of which in one of the patients oligoarthritis arthritis while in the other one the typical seropositive slow-progressing rheumatoid arthritis transformed to RA with systemic manifestations." 11/04/1975 - "[Rumalon in the treatment of secondary arthrosis in patients with rheumatoid arthritis (author's transl)]." 11/01/1995 - "Drugs which potentially protect cartilage from damage, such as orgotein, glycosaminoglycan polysulphate (Arteparon), and Rumalon, may prove useful in rheumatoid arthritis; they have been studied in osteoarthritis, but there is evidence that they protect cartilage from breakdown by inflammation in some animal models. "
5.	Pain (Aches) 01/01/1997 - "Rumalon is an effective agent against pain syndrome in gonarthrosis patients, preserves and improves joint function. " 02/01/2000 - "Whether these phenomena can be correlated with the postulated therapeutic effect of Rumalon in patients with OA remains to be seen, but pain relief via release of endorphins by Th2 cells could be one explanation."

Related Drugs and Biologics

1.	Glycosaminoglycans
2.	Peptides (Polypeptides)
3.	Acids
4.	Indomethacin (Indometacin)
5.	Immunoglobulins (Immunoglobulin)
6.	Antibodies
7.	Arteparon
8.	Therapeutic Uses
9.	Antirheumatic Agents (DMARD)
10.	Cytokines

Related Therapies and Procedures

1.	Therapeutics
2.	Organotherapy
3.	Intramuscular Injections
4.	Injections
5.	Meniscectomy